Mr Dudderidge is one of the UK’s leaders in prostate cancer management. He is one of a handful of clinicians combining an interest in imaging and precision diagnostics with skills in both focal therapy and robotic assisted laparoscopic surgery.
Mr Dudderidge is one of two surgeons leading the prostate cancer service at University Hospital Southampton. In the past few years he has helped transform the service with innovations in the diagnostic pathway, development of new therapies including High Intensity Focused Ultrasound and focal Cryotherapy and recently led the efforts to deliver a robotic surgery service in the Spire Southampton Hospital.
During the same period Mr Dudderidge has also led the development of a prostate cancer research programme. The work has included evaluation of new urinary markers for cancer detection, investigation of HIFU and new imaging techniques in prostate cancer management. Mr Dudderidge was the principal investigator in Southampton for the PROMIS study. Southampton was the 3rd biggest contributor to the landmark multicentre study which confirmed the value of MP-MRI in prostate cancer assessment.